IBDEI2AY ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38670,1,4,0)
 ;;=4^I69.954
 ;;^UTILITY(U,$J,358.3,38670,2)
 ;;=^5133587
 ;;^UTILITY(U,$J,358.3,38671,0)
 ;;=I69.951^^180^1981^13
 ;;^UTILITY(U,$J,358.3,38671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38671,1,3,0)
 ;;=3^Hemiplga fol unsp cerebvasc disease aff right dominant side
 ;;^UTILITY(U,$J,358.3,38671,1,4,0)
 ;;=4^I69.951
 ;;^UTILITY(U,$J,358.3,38671,2)
 ;;=^5007561
 ;;^UTILITY(U,$J,358.3,38672,0)
 ;;=I69.953^^180^1981^14
 ;;^UTILITY(U,$J,358.3,38672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38672,1,3,0)
 ;;=3^Hemiplga fol unsp cerebvasc disease aff right nondom side
 ;;^UTILITY(U,$J,358.3,38672,1,4,0)
 ;;=4^I69.953
 ;;^UTILITY(U,$J,358.3,38672,2)
 ;;=^5007562
 ;;^UTILITY(U,$J,358.3,38673,0)
 ;;=G81.92^^180^1981^7
 ;;^UTILITY(U,$J,358.3,38673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38673,1,3,0)
 ;;=3^Hemiplegia, unspecified affecting left dominant side
 ;;^UTILITY(U,$J,358.3,38673,1,4,0)
 ;;=4^G81.92
 ;;^UTILITY(U,$J,358.3,38673,2)
 ;;=^5004122
 ;;^UTILITY(U,$J,358.3,38674,0)
 ;;=G81.94^^180^1981^8
 ;;^UTILITY(U,$J,358.3,38674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38674,1,3,0)
 ;;=3^Hemiplegia, unspecified affecting left nondominant side
 ;;^UTILITY(U,$J,358.3,38674,1,4,0)
 ;;=4^G81.94
 ;;^UTILITY(U,$J,358.3,38674,2)
 ;;=^5004124
 ;;^UTILITY(U,$J,358.3,38675,0)
 ;;=G81.91^^180^1981^9
 ;;^UTILITY(U,$J,358.3,38675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38675,1,3,0)
 ;;=3^Hemiplegia, unspecified affecting right dominant side
 ;;^UTILITY(U,$J,358.3,38675,1,4,0)
 ;;=4^G81.91
 ;;^UTILITY(U,$J,358.3,38675,2)
 ;;=^5004121
 ;;^UTILITY(U,$J,358.3,38676,0)
 ;;=G81.93^^180^1981^10
 ;;^UTILITY(U,$J,358.3,38676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38676,1,3,0)
 ;;=3^Hemiplegia, unspecified affecting right nondominant side
 ;;^UTILITY(U,$J,358.3,38676,1,4,0)
 ;;=4^G81.93
 ;;^UTILITY(U,$J,358.3,38676,2)
 ;;=^5004123
 ;;^UTILITY(U,$J,358.3,38677,0)
 ;;=I69.942^^180^1981^23
 ;;^UTILITY(U,$J,358.3,38677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38677,1,3,0)
 ;;=3^Monoplg low lmb fol unsp cerebvasc dis aff left dom side
 ;;^UTILITY(U,$J,358.3,38677,1,4,0)
 ;;=4^I69.942
 ;;^UTILITY(U,$J,358.3,38677,2)
 ;;=^5133582
 ;;^UTILITY(U,$J,358.3,38678,0)
 ;;=I69.944^^180^1981^24
 ;;^UTILITY(U,$J,358.3,38678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38678,1,3,0)
 ;;=3^Monoplg low lmb fol unsp cerebvasc dis aff left nondom side
 ;;^UTILITY(U,$J,358.3,38678,1,4,0)
 ;;=4^I69.944
 ;;^UTILITY(U,$J,358.3,38678,2)
 ;;=^5133585
 ;;^UTILITY(U,$J,358.3,38679,0)
 ;;=I69.941^^180^1981^25
 ;;^UTILITY(U,$J,358.3,38679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38679,1,3,0)
 ;;=3^Monoplg low lmb fol unsp cerebvasc dis aff right dom side
 ;;^UTILITY(U,$J,358.3,38679,1,4,0)
 ;;=4^I69.941
 ;;^UTILITY(U,$J,358.3,38679,2)
 ;;=^5133581
 ;;^UTILITY(U,$J,358.3,38680,0)
 ;;=I69.943^^180^1981^26
 ;;^UTILITY(U,$J,358.3,38680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38680,1,3,0)
 ;;=3^Monoplg low lmb fol unsp cerebvasc dis aff right nondom side
 ;;^UTILITY(U,$J,358.3,38680,1,4,0)
 ;;=4^I69.943
 ;;^UTILITY(U,$J,358.3,38680,2)
 ;;=^5133584
 ;;^UTILITY(U,$J,358.3,38681,0)
 ;;=G35.^^180^1981^27
 ;;^UTILITY(U,$J,358.3,38681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38681,1,3,0)
 ;;=3^Multiple sclerosis
 ;;^UTILITY(U,$J,358.3,38681,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,38681,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,38682,0)
 ;;=G20.^^180^1981^28
 ;;^UTILITY(U,$J,358.3,38682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38682,1,3,0)
 ;;=3^Parkinson's disease
 ;;^UTILITY(U,$J,358.3,38682,1,4,0)
 ;;=4^G20.
